nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—chronic kidney failure—Furosemide—coronary artery disease	0.738	1	CpDpCtD
Deferoxamine—XDH—Effects of Nitric Oxide—MB—coronary artery disease	0.0109	0.16	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—HBA1—coronary artery disease	0.00394	0.0579	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—PPAT—coronary artery disease	0.00266	0.0391	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—CAT—coronary artery disease	0.00217	0.0319	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD3—coronary artery disease	0.00203	0.0298	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX6—coronary artery disease	0.00197	0.0289	CbGpPWpGaD
Deferoxamine—XDH—Purine catabolism—GPX1—coronary artery disease	0.00196	0.0288	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—TXNRD1—coronary artery disease	0.00196	0.0288	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS2—coronary artery disease	0.00188	0.0276	CbGpPWpGaD
Deferoxamine—XDH—Effects of Nitric Oxide—NOS3—coronary artery disease	0.00151	0.0222	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GPX3—coronary artery disease	0.00146	0.0215	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—AK1—coronary artery disease	0.0014	0.0205	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—PPAT—coronary artery disease	0.00134	0.0197	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GCLC—coronary artery disease	0.00132	0.0194	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CYBA—coronary artery disease	0.00119	0.0175	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—JUNB—coronary artery disease	0.0011	0.0162	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD1—coronary artery disease	0.000948	0.0139	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—TXNRD1—coronary artery disease	0.000913	0.0134	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—HMOX1—coronary artery disease	0.000913	0.0134	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—CAT—coronary artery disease	0.000901	0.0132	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD3—coronary artery disease	0.000856	0.0126	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—SOD2—coronary artery disease	0.000854	0.0125	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—CAT—coronary artery disease	0.000834	0.0123	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—TXNRD1—coronary artery disease	0.000829	0.0122	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—GPX1—coronary artery disease	0.000814	0.012	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX2—coronary artery disease	0.000763	0.0112	CbGpPWpGaD
Deferoxamine—XDH—Purine metabolism—GPX1—coronary artery disease	0.000755	0.0111	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX4—coronary artery disease	0.000754	0.0111	CbGpPWpGaD
Deferoxamine—XDH—Oxidative Stress—MAPK14—coronary artery disease	0.000681	0.01	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX3—coronary artery disease	0.000619	0.0091	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—HBA1—coronary artery disease	0.000578	0.0085	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—MPO—coronary artery disease	0.000575	0.00845	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—LDLR—coronary artery disease	0.000571	0.0084	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—F7—coronary artery disease	0.000552	0.00811	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PLAT—coronary artery disease	0.000492	0.00723	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ABCA1—coronary artery disease	0.00045	0.00661	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GGT1—coronary artery disease	0.000436	0.0064	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—CAT—coronary artery disease	0.000419	0.00616	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PLG—coronary artery disease	0.000418	0.00615	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD1—coronary artery disease	0.000401	0.00589	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CAT—coronary artery disease	0.000381	0.0056	CbGpPWpGaD
Deferoxamine—XDH—Nucleotide metabolism—GPX1—coronary artery disease	0.000379	0.00557	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—APOB—coronary artery disease	0.00037	0.00543	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SOD2—coronary artery disease	0.000361	0.0053	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—GPX1—coronary artery disease	0.000344	0.00506	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—MTHFR—coronary artery disease	0.000318	0.00467	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CRP—coronary artery disease	0.000302	0.00444	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—APOA1—coronary artery disease	0.000292	0.0043	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—F2—coronary artery disease	0.000279	0.0041	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ICAM1—coronary artery disease	0.000278	0.00408	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—CCL2—coronary artery disease	0.000249	0.00365	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—SERPINE1—coronary artery disease	0.000232	0.00341	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—ALB—coronary artery disease	0.000232	0.00341	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CA5B—coronary artery disease	0.000231	0.0034	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—PTGS2—coronary artery disease	0.000203	0.00298	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CKMT1B—coronary artery disease	0.000197	0.00289	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—IL1B—coronary artery disease	0.000189	0.00277	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CKM—coronary artery disease	0.00016	0.00236	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UQCRFS1—coronary artery disease	0.00016	0.00236	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPAP2B—coronary artery disease	0.00016	0.00236	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PYGM—coronary artery disease	0.000149	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SULT4A1—coronary artery disease	0.000149	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALDH6A1—coronary artery disease	0.000149	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PDK4—coronary artery disease	0.000149	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CKMT2—coronary artery disease	0.000149	0.00219	CbGpPWpGaD
Deferoxamine—XDH—Selenium Micronutrient Network—TNF—coronary artery disease	0.000137	0.00201	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LDHA—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMGCS2—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GYG1—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GK—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PFKM—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GATM—coronary artery disease	0.000133	0.00195	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCH1—coronary artery disease	0.000127	0.00186	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AK1—coronary artery disease	0.000127	0.00186	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MDH2—coronary artery disease	0.000122	0.00179	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—UGCG—coronary artery disease	0.000122	0.00179	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPAT—coronary artery disease	0.000122	0.00179	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLCD1—coronary artery disease	0.000122	0.00179	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PGM1—coronary artery disease	0.000117	0.00172	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CKB—coronary artery disease	0.000113	0.00166	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PYGB—coronary artery disease	0.000113	0.00166	CbGpPWpGaD
Deferoxamine—Tachycardia—Losartan—coronary artery disease	0.000112	0.000578	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000112	0.000577	CcSEcCtD
Deferoxamine—Abdominal pain—Olmesartan—coronary artery disease	0.000112	0.000576	CcSEcCtD
Deferoxamine—Body temperature increased—Olmesartan—coronary artery disease	0.000112	0.000576	CcSEcCtD
Deferoxamine—Pruritus—Ezetimibe—coronary artery disease	0.000111	0.000575	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Perindopril—coronary artery disease	0.000111	0.000575	CcSEcCtD
Deferoxamine—Hypotension—Furosemide—coronary artery disease	0.000111	0.000573	CcSEcCtD
Deferoxamine—Vision blurred—Timolol—coronary artery disease	0.000111	0.000573	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Pravastatin—coronary artery disease	0.000111	0.000573	CcSEcCtD
Deferoxamine—Pain—Telmisartan—coronary artery disease	0.000111	0.000572	CcSEcCtD
Deferoxamine—Hypersensitivity—Simvastatin—coronary artery disease	0.000111	0.000571	CcSEcCtD
Deferoxamine—Diarrhoea—Clopidogrel—coronary artery disease	0.000111	0.000571	CcSEcCtD
Deferoxamine—XDH—Selenium Micronutrient Network—IL6—coronary artery disease	0.00011	0.00162	CbGpPWpGaD
Deferoxamine—Angioedema—Ramipril—coronary artery disease	0.00011	0.000568	CcSEcCtD
Deferoxamine—Diarrhoea—Lovastatin—coronary artery disease	0.00011	0.000567	CcSEcCtD
Deferoxamine—Paraesthesia—Perindopril—coronary artery disease	0.00011	0.000567	CcSEcCtD
Deferoxamine—Urticaria—Niacin—coronary artery disease	0.00011	0.000566	CcSEcCtD
Deferoxamine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000109	0.000564	CcSEcCtD
Deferoxamine—Erythema—Lisinopril—coronary artery disease	0.000109	0.000564	CcSEcCtD
Deferoxamine—Pruritus—Eplerenone—coronary artery disease	0.000109	0.000563	CcSEcCtD
Deferoxamine—Dyspnoea—Perindopril—coronary artery disease	0.000109	0.000563	CcSEcCtD
Deferoxamine—Abdominal pain—Niacin—coronary artery disease	0.000109	0.000563	CcSEcCtD
Deferoxamine—Body temperature increased—Niacin—coronary artery disease	0.000109	0.000563	CcSEcCtD
Deferoxamine—Dizziness—Fenofibrate—coronary artery disease	0.000109	0.000561	CcSEcCtD
Deferoxamine—Leukopenia—Ramipril—coronary artery disease	0.000108	0.000557	CcSEcCtD
Deferoxamine—Urticaria—Pravastatin—coronary artery disease	0.000108	0.000557	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Trandolapril—coronary artery disease	0.000108	0.000557	CcSEcCtD
Deferoxamine—Diarrhoea—Ezetimibe—coronary artery disease	0.000108	0.000556	CcSEcCtD
Deferoxamine—Angioedema—Timolol—coronary artery disease	0.000108	0.000556	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Enalapril—coronary artery disease	0.000107	0.000554	CcSEcCtD
Deferoxamine—Abdominal pain—Pravastatin—coronary artery disease	0.000107	0.000554	CcSEcCtD
Deferoxamine—Body temperature increased—Pravastatin—coronary artery disease	0.000107	0.000554	CcSEcCtD
Deferoxamine—Hypotension—Losartan—coronary artery disease	0.000107	0.000553	CcSEcCtD
Deferoxamine—Dizziness—Clopidogrel—coronary artery disease	0.000107	0.000552	CcSEcCtD
Deferoxamine—Paraesthesia—Furosemide—coronary artery disease	0.000107	0.000551	CcSEcCtD
Deferoxamine—Pruritus—Simvastatin—coronary artery disease	0.000106	0.000549	CcSEcCtD
Deferoxamine—XDH—Metabolism—PFKFB3—coronary artery disease	0.000106	0.00156	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—COX5B—coronary artery disease	0.000106	0.00156	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—DLAT—coronary artery disease	0.000106	0.00156	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTM2—coronary artery disease	0.000106	0.00156	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLIN1—coronary artery disease	0.000106	0.00156	CbGpPWpGaD
Deferoxamine—Dizziness—Lovastatin—coronary artery disease	0.000106	0.000548	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Telmisartan—coronary artery disease	0.000106	0.000547	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000106	0.000545	CcSEcCtD
Deferoxamine—Diarrhoea—Eplerenone—coronary artery disease	0.000106	0.000544	CcSEcCtD
Deferoxamine—Muscle spasms—Lisinopril—coronary artery disease	0.000105	0.000542	CcSEcCtD
Deferoxamine—Urticaria—Trandolapril—coronary artery disease	0.000105	0.000541	CcSEcCtD
Deferoxamine—Pain—Perindopril—coronary artery disease	0.000105	0.00054	CcSEcCtD
Deferoxamine—Vomiting—Fenofibrate—coronary artery disease	0.000105	0.00054	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Losartan—coronary artery disease	0.000105	0.000539	CcSEcCtD
Deferoxamine—Hypersensitivity—Valsartan—coronary artery disease	0.000105	0.000539	CcSEcCtD
Deferoxamine—Convulsion—Ramipril—coronary artery disease	0.000104	0.000539	CcSEcCtD
Deferoxamine—Urticaria—Enalapril—coronary artery disease	0.000104	0.000539	CcSEcCtD
Deferoxamine—Body temperature increased—Trandolapril—coronary artery disease	0.000104	0.000538	CcSEcCtD
Deferoxamine—Abdominal pain—Trandolapril—coronary artery disease	0.000104	0.000538	CcSEcCtD
Deferoxamine—Dizziness—Ezetimibe—coronary artery disease	0.000104	0.000538	CcSEcCtD
Deferoxamine—Body temperature increased—Enalapril—coronary artery disease	0.000104	0.000536	CcSEcCtD
Deferoxamine—Abdominal pain—Enalapril—coronary artery disease	0.000104	0.000536	CcSEcCtD
Deferoxamine—Headache—Fenofibrate—coronary artery disease	0.000103	0.000532	CcSEcCtD
Deferoxamine—Vision blurred—Lisinopril—coronary artery disease	0.000103	0.000532	CcSEcCtD
Deferoxamine—Paraesthesia—Losartan—coronary artery disease	0.000103	0.000532	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Captopril—coronary artery disease	0.000103	0.000532	CcSEcCtD
Deferoxamine—Urticaria—Telmisartan—coronary artery disease	0.000103	0.000531	CcSEcCtD
Deferoxamine—Vomiting—Clopidogrel—coronary artery disease	0.000103	0.000531	CcSEcCtD
Deferoxamine—Diarrhoea—Simvastatin—coronary artery disease	0.000103	0.00053	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000103	0.00053	CcSEcCtD
Deferoxamine—Arthralgia—Ramipril—coronary artery disease	0.000103	0.00053	CcSEcCtD
Deferoxamine—Myalgia—Ramipril—coronary artery disease	0.000103	0.00053	CcSEcCtD
Deferoxamine—Body temperature increased—Telmisartan—coronary artery disease	0.000102	0.000529	CcSEcCtD
Deferoxamine—Abdominal pain—Telmisartan—coronary artery disease	0.000102	0.000529	CcSEcCtD
Deferoxamine—Dyspnoea—Losartan—coronary artery disease	0.000102	0.000528	CcSEcCtD
Deferoxamine—Vomiting—Lovastatin—coronary artery disease	0.000102	0.000527	CcSEcCtD
Deferoxamine—Dizziness—Eplerenone—coronary artery disease	0.000102	0.000526	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000102	0.000526	CcSEcCtD
Deferoxamine—Pain—Furosemide—coronary artery disease	0.000102	0.000525	CcSEcCtD
Deferoxamine—Hypersensitivity—Niacin—coronary artery disease	0.000102	0.000524	CcSEcCtD
Deferoxamine—Headache—Clopidogrel—coronary artery disease	0.000101	0.000523	CcSEcCtD
Deferoxamine—XDH—Metabolism—SULT1E1—coronary artery disease	0.000101	0.00148	CbGpPWpGaD
Deferoxamine—Headache—Lovastatin—coronary artery disease	0.000101	0.000519	CcSEcCtD
Deferoxamine—Pruritus—Valsartan—coronary artery disease	0.0001	0.000518	CcSEcCtD
Deferoxamine—Myalgia—Timolol—coronary artery disease	0.0001	0.000518	CcSEcCtD
Deferoxamine—Arthralgia—Timolol—coronary artery disease	0.0001	0.000518	CcSEcCtD
Deferoxamine—Vomiting—Ezetimibe—coronary artery disease	0.0001	0.000517	CcSEcCtD
Deferoxamine—Hypersensitivity—Pravastatin—coronary artery disease	0.0001	0.000516	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Perindopril—coronary artery disease	0.0001	0.000516	CcSEcCtD
Deferoxamine—Angioedema—Lisinopril—coronary artery disease	9.99e-05	0.000516	CcSEcCtD
Deferoxamine—Pruritus—Olmesartan—coronary artery disease	9.99e-05	0.000516	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.96e-05	0.000514	CcSEcCtD
Deferoxamine—Body temperature increased—Captopril—coronary artery disease	9.96e-05	0.000514	CcSEcCtD
Deferoxamine—Abdominal pain—Captopril—coronary artery disease	9.96e-05	0.000514	CcSEcCtD
Deferoxamine—Dizziness—Simvastatin—coronary artery disease	9.94e-05	0.000513	CcSEcCtD
Deferoxamine—Headache—Ezetimibe—coronary artery disease	9.87e-05	0.000509	CcSEcCtD
Deferoxamine—Oedema—Ramipril—coronary artery disease	9.84e-05	0.000508	CcSEcCtD
Deferoxamine—Anaphylactic shock—Ramipril—coronary artery disease	9.84e-05	0.000508	CcSEcCtD
Deferoxamine—Pain—Losartan—coronary artery disease	9.81e-05	0.000506	CcSEcCtD
Deferoxamine—Vomiting—Eplerenone—coronary artery disease	9.8e-05	0.000506	CcSEcCtD
Deferoxamine—Leukopenia—Lisinopril—coronary artery disease	9.79e-05	0.000505	CcSEcCtD
Deferoxamine—Nausea—Fenofibrate—coronary artery disease	9.77e-05	0.000504	CcSEcCtD
Deferoxamine—Pruritus—Niacin—coronary artery disease	9.76e-05	0.000504	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Furosemide—coronary artery disease	9.72e-05	0.000502	CcSEcCtD
Deferoxamine—Urticaria—Perindopril—coronary artery disease	9.72e-05	0.000502	CcSEcCtD
Deferoxamine—Hypersensitivity—Trandolapril—coronary artery disease	9.72e-05	0.000501	CcSEcCtD
Deferoxamine—Diarrhoea—Valsartan—coronary artery disease	9.71e-05	0.000501	CcSEcCtD
Deferoxamine—Shock—Ramipril—coronary artery disease	9.68e-05	0.0005	CcSEcCtD
Deferoxamine—Hypersensitivity—Enalapril—coronary artery disease	9.68e-05	0.000499	CcSEcCtD
Deferoxamine—Abdominal pain—Perindopril—coronary artery disease	9.67e-05	0.000499	CcSEcCtD
Deferoxamine—Body temperature increased—Perindopril—coronary artery disease	9.67e-05	0.000499	CcSEcCtD
Deferoxamine—Diarrhoea—Olmesartan—coronary artery disease	9.66e-05	0.000499	CcSEcCtD
Deferoxamine—Headache—Eplerenone—coronary artery disease	9.66e-05	0.000498	CcSEcCtD
Deferoxamine—Nervous system disorder—Ramipril—coronary artery disease	9.65e-05	0.000498	CcSEcCtD
Deferoxamine—Thrombocytopenia—Ramipril—coronary artery disease	9.63e-05	0.000497	CcSEcCtD
Deferoxamine—Oedema—Timolol—coronary artery disease	9.62e-05	0.000496	CcSEcCtD
Deferoxamine—Anaphylactic shock—Timolol—coronary artery disease	9.62e-05	0.000496	CcSEcCtD
Deferoxamine—XDH—Metabolism—AKR1B1—coronary artery disease	9.61e-05	0.00141	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HK2—coronary artery disease	9.61e-05	0.00141	CbGpPWpGaD
Deferoxamine—Pruritus—Pravastatin—coronary artery disease	9.61e-05	0.000496	CcSEcCtD
Deferoxamine—Nausea—Clopidogrel—coronary artery disease	9.6e-05	0.000496	CcSEcCtD
Deferoxamine—Tachycardia—Ramipril—coronary artery disease	9.6e-05	0.000496	CcSEcCtD
Deferoxamine—Skin disorder—Ramipril—coronary artery disease	9.56e-05	0.000493	CcSEcCtD
Deferoxamine—Infection—Timolol—coronary artery disease	9.56e-05	0.000493	CcSEcCtD
Deferoxamine—Vomiting—Simvastatin—coronary artery disease	9.55e-05	0.000493	CcSEcCtD
Deferoxamine—Hypersensitivity—Telmisartan—coronary artery disease	9.55e-05	0.000493	CcSEcCtD
Deferoxamine—Nausea—Lovastatin—coronary artery disease	9.54e-05	0.000492	CcSEcCtD
Deferoxamine—Shock—Timolol—coronary artery disease	9.46e-05	0.000488	CcSEcCtD
Deferoxamine—Urticaria—Furosemide—coronary artery disease	9.45e-05	0.000488	CcSEcCtD
Deferoxamine—Diarrhoea—Niacin—coronary artery disease	9.44e-05	0.000487	CcSEcCtD
Deferoxamine—Nervous system disorder—Timolol—coronary artery disease	9.43e-05	0.000487	CcSEcCtD
Deferoxamine—Headache—Simvastatin—coronary artery disease	9.41e-05	0.000486	CcSEcCtD
Deferoxamine—Body temperature increased—Furosemide—coronary artery disease	9.4e-05	0.000485	CcSEcCtD
Deferoxamine—Abdominal pain—Furosemide—coronary artery disease	9.4e-05	0.000485	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Losartan—coronary artery disease	9.38e-05	0.000484	CcSEcCtD
Deferoxamine—Dizziness—Valsartan—coronary artery disease	9.38e-05	0.000484	CcSEcCtD
Deferoxamine—Nausea—Ezetimibe—coronary artery disease	9.36e-05	0.000483	CcSEcCtD
Deferoxamine—Skin disorder—Timolol—coronary artery disease	9.34e-05	0.000482	CcSEcCtD
Deferoxamine—Dizziness—Olmesartan—coronary artery disease	9.34e-05	0.000482	CcSEcCtD
Deferoxamine—Pruritus—Trandolapril—coronary artery disease	9.33e-05	0.000482	CcSEcCtD
Deferoxamine—Myalgia—Lisinopril—coronary artery disease	9.31e-05	0.00048	CcSEcCtD
Deferoxamine—Arthralgia—Lisinopril—coronary artery disease	9.31e-05	0.00048	CcSEcCtD
Deferoxamine—Pruritus—Enalapril—coronary artery disease	9.29e-05	0.00048	CcSEcCtD
Deferoxamine—Diarrhoea—Pravastatin—coronary artery disease	9.29e-05	0.00048	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	9.24e-05	0.000477	CcSEcCtD
Deferoxamine—XDH—Metabolism—SLC27A1—coronary artery disease	9.21e-05	0.00135	CbGpPWpGaD
Deferoxamine—Hypotension—Ramipril—coronary artery disease	9.19e-05	0.000474	CcSEcCtD
Deferoxamine—Pruritus—Telmisartan—coronary artery disease	9.17e-05	0.000473	CcSEcCtD
Deferoxamine—Nausea—Eplerenone—coronary artery disease	9.16e-05	0.000473	CcSEcCtD
Deferoxamine—Dizziness—Niacin—coronary artery disease	9.12e-05	0.000471	CcSEcCtD
Deferoxamine—Urticaria—Losartan—coronary artery disease	9.12e-05	0.00047	CcSEcCtD
Deferoxamine—Body temperature increased—Losartan—coronary artery disease	9.07e-05	0.000468	CcSEcCtD
Deferoxamine—Abdominal pain—Losartan—coronary artery disease	9.07e-05	0.000468	CcSEcCtD
Deferoxamine—XDH—Metabolism—CPT1B—coronary artery disease	9.04e-05	0.00133	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LCAT—coronary artery disease	9.04e-05	0.00133	CbGpPWpGaD
Deferoxamine—Diarrhoea—Trandolapril—coronary artery disease	9.02e-05	0.000466	CcSEcCtD
Deferoxamine—Vomiting—Valsartan—coronary artery disease	9.02e-05	0.000466	CcSEcCtD
Deferoxamine—Diarrhoea—Enalapril—coronary artery disease	8.99e-05	0.000464	CcSEcCtD
Deferoxamine—Hypotension—Timolol—coronary artery disease	8.99e-05	0.000464	CcSEcCtD
Deferoxamine—Dizziness—Pravastatin—coronary artery disease	8.98e-05	0.000464	CcSEcCtD
Deferoxamine—Vomiting—Olmesartan—coronary artery disease	8.98e-05	0.000463	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.96e-05	0.000463	CcSEcCtD
Deferoxamine—Nausea—Simvastatin—coronary artery disease	8.92e-05	0.000461	CcSEcCtD
Deferoxamine—Anaphylactic shock—Lisinopril—coronary artery disease	8.92e-05	0.00046	CcSEcCtD
Deferoxamine—Oedema—Lisinopril—coronary artery disease	8.92e-05	0.00046	CcSEcCtD
Deferoxamine—Pruritus—Captopril—coronary artery disease	8.91e-05	0.00046	CcSEcCtD
Deferoxamine—Headache—Valsartan—coronary artery disease	8.89e-05	0.000459	CcSEcCtD
Deferoxamine—XDH—Metabolism—APOA4—coronary artery disease	8.87e-05	0.0013	CbGpPWpGaD
Deferoxamine—Diarrhoea—Telmisartan—coronary artery disease	8.87e-05	0.000458	CcSEcCtD
Deferoxamine—Infection—Lisinopril—coronary artery disease	8.86e-05	0.000457	CcSEcCtD
Deferoxamine—Headache—Olmesartan—coronary artery disease	8.85e-05	0.000456	CcSEcCtD
Deferoxamine—Paraesthesia—Ramipril—coronary artery disease	8.84e-05	0.000456	CcSEcCtD
Deferoxamine—Shock—Lisinopril—coronary artery disease	8.78e-05	0.000453	CcSEcCtD
Deferoxamine—Dyspnoea—Ramipril—coronary artery disease	8.77e-05	0.000453	CcSEcCtD
Deferoxamine—Vomiting—Niacin—coronary artery disease	8.77e-05	0.000453	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Timolol—coronary artery disease	8.76e-05	0.000452	CcSEcCtD
Deferoxamine—Hypersensitivity—Furosemide—coronary artery disease	8.76e-05	0.000452	CcSEcCtD
Deferoxamine—Thrombocytopenia—Lisinopril—coronary artery disease	8.74e-05	0.000451	CcSEcCtD
Deferoxamine—Dizziness—Trandolapril—coronary artery disease	8.72e-05	0.00045	CcSEcCtD
Deferoxamine—Tachycardia—Lisinopril—coronary artery disease	8.71e-05	0.000449	CcSEcCtD
Deferoxamine—Dizziness—Enalapril—coronary artery disease	8.69e-05	0.000448	CcSEcCtD
Deferoxamine—Skin disorder—Lisinopril—coronary artery disease	8.67e-05	0.000447	CcSEcCtD
Deferoxamine—Pruritus—Perindopril—coronary artery disease	8.66e-05	0.000447	CcSEcCtD
Deferoxamine—Headache—Niacin—coronary artery disease	8.64e-05	0.000446	CcSEcCtD
Deferoxamine—Paraesthesia—Timolol—coronary artery disease	8.64e-05	0.000446	CcSEcCtD
Deferoxamine—Vomiting—Pravastatin—coronary artery disease	8.64e-05	0.000446	CcSEcCtD
Deferoxamine—Diarrhoea—Captopril—coronary artery disease	8.62e-05	0.000445	CcSEcCtD
Deferoxamine—Dyspnoea—Timolol—coronary artery disease	8.58e-05	0.000443	CcSEcCtD
Deferoxamine—Dizziness—Telmisartan—coronary artery disease	8.57e-05	0.000442	CcSEcCtD
Deferoxamine—XDH—Metabolism—PDHA1—coronary artery disease	8.57e-05	0.00126	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCLM—coronary artery disease	8.57e-05	0.00126	CbGpPWpGaD
Deferoxamine—Headache—Pravastatin—coronary artery disease	8.51e-05	0.000439	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Ramipril—coronary artery disease	8.49e-05	0.000438	CcSEcCtD
Deferoxamine—Hypersensitivity—Losartan—coronary artery disease	8.45e-05	0.000436	CcSEcCtD
Deferoxamine—Nausea—Valsartan—coronary artery disease	8.43e-05	0.000435	CcSEcCtD
Deferoxamine—Pruritus—Furosemide—coronary artery disease	8.41e-05	0.000434	CcSEcCtD
Deferoxamine—Nausea—Olmesartan—coronary artery disease	8.39e-05	0.000433	CcSEcCtD
Deferoxamine—Vomiting—Trandolapril—coronary artery disease	8.39e-05	0.000433	CcSEcCtD
Deferoxamine—Diarrhoea—Perindopril—coronary artery disease	8.37e-05	0.000432	CcSEcCtD
Deferoxamine—Vomiting—Enalapril—coronary artery disease	8.35e-05	0.000431	CcSEcCtD
Deferoxamine—Hypotension—Lisinopril—coronary artery disease	8.34e-05	0.00043	CcSEcCtD
Deferoxamine—Dizziness—Captopril—coronary artery disease	8.33e-05	0.00043	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Timolol—coronary artery disease	8.3e-05	0.000429	CcSEcCtD
Deferoxamine—XDH—Metabolism—CYP11B2—coronary artery disease	8.3e-05	0.00122	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—TXNRD1—coronary artery disease	8.3e-05	0.00122	CbGpPWpGaD
Deferoxamine—Headache—Trandolapril—coronary artery disease	8.26e-05	0.000426	CcSEcCtD
Deferoxamine—Vomiting—Telmisartan—coronary artery disease	8.24e-05	0.000425	CcSEcCtD
Deferoxamine—Headache—Enalapril—coronary artery disease	8.23e-05	0.000425	CcSEcCtD
Deferoxamine—Pain—Timolol—coronary artery disease	8.23e-05	0.000424	CcSEcCtD
Deferoxamine—Nausea—Niacin—coronary artery disease	8.19e-05	0.000423	CcSEcCtD
Deferoxamine—XDH—Metabolism—SLC22A3—coronary artery disease	8.17e-05	0.0012	CbGpPWpGaD
Deferoxamine—Diarrhoea—Furosemide—coronary artery disease	8.14e-05	0.00042	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Lisinopril—coronary artery disease	8.13e-05	0.00042	CcSEcCtD
Deferoxamine—Pruritus—Losartan—coronary artery disease	8.12e-05	0.000419	CcSEcCtD
Deferoxamine—Headache—Telmisartan—coronary artery disease	8.12e-05	0.000419	CcSEcCtD
Deferoxamine—Dizziness—Perindopril—coronary artery disease	8.09e-05	0.000417	CcSEcCtD
Deferoxamine—Nausea—Pravastatin—coronary artery disease	8.07e-05	0.000416	CcSEcCtD
Deferoxamine—XDH—Metabolism—ARNTL—coronary artery disease	8.05e-05	0.00118	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HADH—coronary artery disease	8.05e-05	0.00118	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Ramipril—coronary artery disease	8.05e-05	0.000415	CcSEcCtD
Deferoxamine—Paraesthesia—Lisinopril—coronary artery disease	8.01e-05	0.000413	CcSEcCtD
Deferoxamine—Vomiting—Captopril—coronary artery disease	8.01e-05	0.000413	CcSEcCtD
Deferoxamine—Dyspnoea—Lisinopril—coronary artery disease	7.96e-05	0.000411	CcSEcCtD
Deferoxamine—Headache—Captopril—coronary artery disease	7.89e-05	0.000407	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Timolol—coronary artery disease	7.87e-05	0.000406	CcSEcCtD
Deferoxamine—Dizziness—Furosemide—coronary artery disease	7.86e-05	0.000406	CcSEcCtD
Deferoxamine—Diarrhoea—Losartan—coronary artery disease	7.85e-05	0.000405	CcSEcCtD
Deferoxamine—Nausea—Trandolapril—coronary artery disease	7.83e-05	0.000404	CcSEcCtD
Deferoxamine—Urticaria—Ramipril—coronary artery disease	7.82e-05	0.000403	CcSEcCtD
Deferoxamine—Nausea—Enalapril—coronary artery disease	7.8e-05	0.000403	CcSEcCtD
Deferoxamine—Vomiting—Perindopril—coronary artery disease	7.78e-05	0.000401	CcSEcCtD
Deferoxamine—Abdominal pain—Ramipril—coronary artery disease	7.78e-05	0.000401	CcSEcCtD
Deferoxamine—Body temperature increased—Ramipril—coronary artery disease	7.78e-05	0.000401	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.7e-05	0.000398	CcSEcCtD
Deferoxamine—Nausea—Telmisartan—coronary artery disease	7.7e-05	0.000397	CcSEcCtD
Deferoxamine—Headache—Perindopril—coronary artery disease	7.66e-05	0.000395	CcSEcCtD
Deferoxamine—Urticaria—Timolol—coronary artery disease	7.64e-05	0.000394	CcSEcCtD
Deferoxamine—XDH—Metabolism—GPX2—coronary artery disease	7.63e-05	0.00112	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLA2G2A—coronary artery disease	7.63e-05	0.00112	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA2—coronary artery disease	7.63e-05	0.00112	CbGpPWpGaD
Deferoxamine—Pain—Lisinopril—coronary artery disease	7.63e-05	0.000394	CcSEcCtD
Deferoxamine—Abdominal pain—Timolol—coronary artery disease	7.6e-05	0.000392	CcSEcCtD
Deferoxamine—Body temperature increased—Timolol—coronary artery disease	7.6e-05	0.000392	CcSEcCtD
Deferoxamine—Dizziness—Losartan—coronary artery disease	7.59e-05	0.000392	CcSEcCtD
Deferoxamine—Vomiting—Furosemide—coronary artery disease	7.56e-05	0.00039	CcSEcCtD
Deferoxamine—XDH—Metabolism—SULT1A1—coronary artery disease	7.54e-05	0.00111	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPX4—coronary artery disease	7.54e-05	0.00111	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HK1—coronary artery disease	7.54e-05	0.00111	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ABCG5—coronary artery disease	7.54e-05	0.00111	CbGpPWpGaD
Deferoxamine—Nausea—Captopril—coronary artery disease	7.48e-05	0.000386	CcSEcCtD
Deferoxamine—XDH—Metabolism—HADHA—coronary artery disease	7.45e-05	0.0011	CbGpPWpGaD
Deferoxamine—Headache—Furosemide—coronary artery disease	7.45e-05	0.000384	CcSEcCtD
Deferoxamine—XDH—Metabolism—GSTA1—coronary artery disease	7.37e-05	0.00108	CbGpPWpGaD
Deferoxamine—Gastrointestinal pain—Lisinopril—coronary artery disease	7.3e-05	0.000377	CcSEcCtD
Deferoxamine—Vomiting—Losartan—coronary artery disease	7.3e-05	0.000376	CcSEcCtD
Deferoxamine—XDH—Metabolism—LPA—coronary artery disease	7.28e-05	0.00107	CbGpPWpGaD
Deferoxamine—Nausea—Perindopril—coronary artery disease	7.27e-05	0.000375	CcSEcCtD
Deferoxamine—Hypersensitivity—Ramipril—coronary artery disease	7.25e-05	0.000374	CcSEcCtD
Deferoxamine—Headache—Losartan—coronary artery disease	7.19e-05	0.000371	CcSEcCtD
Deferoxamine—Urticaria—Lisinopril—coronary artery disease	7.09e-05	0.000366	CcSEcCtD
Deferoxamine—Hypersensitivity—Timolol—coronary artery disease	7.09e-05	0.000366	CcSEcCtD
Deferoxamine—Nausea—Furosemide—coronary artery disease	7.06e-05	0.000365	CcSEcCtD
Deferoxamine—Abdominal pain—Lisinopril—coronary artery disease	7.05e-05	0.000364	CcSEcCtD
Deferoxamine—Body temperature increased—Lisinopril—coronary artery disease	7.05e-05	0.000364	CcSEcCtD
Deferoxamine—XDH—Metabolism—PLCB3—coronary artery disease	7.05e-05	0.00104	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA5—coronary artery disease	6.98e-05	0.00103	CbGpPWpGaD
Deferoxamine—Pruritus—Ramipril—coronary artery disease	6.96e-05	0.000359	CcSEcCtD
Deferoxamine—XDH—Metabolism—P4HB—coronary artery disease	6.85e-05	0.00101	CbGpPWpGaD
Deferoxamine—Nausea—Losartan—coronary artery disease	6.82e-05	0.000352	CcSEcCtD
Deferoxamine—Pruritus—Timolol—coronary artery disease	6.81e-05	0.000351	CcSEcCtD
Deferoxamine—Diarrhoea—Ramipril—coronary artery disease	6.73e-05	0.000347	CcSEcCtD
Deferoxamine—XDH—Metabolism—PLA2G1B—coronary artery disease	6.72e-05	0.000988	CbGpPWpGaD
Deferoxamine—Diarrhoea—Timolol—coronary artery disease	6.58e-05	0.00034	CcSEcCtD
Deferoxamine—Hypersensitivity—Lisinopril—coronary artery disease	6.57e-05	0.000339	CcSEcCtD
Deferoxamine—Dizziness—Ramipril—coronary artery disease	6.51e-05	0.000336	CcSEcCtD
Deferoxamine—Dizziness—Timolol—coronary artery disease	6.36e-05	0.000328	CcSEcCtD
Deferoxamine—XDH—Metabolism—VCAN—coronary artery disease	6.34e-05	0.000931	CbGpPWpGaD
Deferoxamine—Pruritus—Lisinopril—coronary artery disease	6.31e-05	0.000326	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDOA—coronary artery disease	6.29e-05	0.000924	CbGpPWpGaD
Deferoxamine—Vomiting—Ramipril—coronary artery disease	6.26e-05	0.000323	CcSEcCtD
Deferoxamine—Headache—Ramipril—coronary artery disease	6.16e-05	0.000318	CcSEcCtD
Deferoxamine—Vomiting—Timolol—coronary artery disease	6.12e-05	0.000316	CcSEcCtD
Deferoxamine—Diarrhoea—Lisinopril—coronary artery disease	6.11e-05	0.000315	CcSEcCtD
Deferoxamine—XDH—Metabolism—DCN—coronary artery disease	6.1e-05	0.000897	CbGpPWpGaD
Deferoxamine—Headache—Timolol—coronary artery disease	6.03e-05	0.000311	CcSEcCtD
Deferoxamine—XDH—Metabolism—ALDH2—coronary artery disease	5.94e-05	0.000873	CbGpPWpGaD
Deferoxamine—Dizziness—Lisinopril—coronary artery disease	5.9e-05	0.000305	CcSEcCtD
Deferoxamine—Nausea—Ramipril—coronary artery disease	5.84e-05	0.000302	CcSEcCtD
Deferoxamine—XDH—Metabolism—LIPC—coronary artery disease	5.79e-05	0.00085	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HBA1—coronary artery disease	5.79e-05	0.00085	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CYP2C19—coronary artery disease	5.79e-05	0.00085	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3C2A—coronary artery disease	5.79e-05	0.00085	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOC3—coronary artery disease	5.75e-05	0.000845	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LDLR—coronary artery disease	5.72e-05	0.00084	CbGpPWpGaD
Deferoxamine—Nausea—Timolol—coronary artery disease	5.71e-05	0.000295	CcSEcCtD
Deferoxamine—Vomiting—Lisinopril—coronary artery disease	5.67e-05	0.000293	CcSEcCtD
Deferoxamine—XDH—Metabolism—SLC9A1—coronary artery disease	5.65e-05	0.00083	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTT1—coronary artery disease	5.65e-05	0.00083	CbGpPWpGaD
Deferoxamine—Headache—Lisinopril—coronary artery disease	5.59e-05	0.000288	CcSEcCtD
Deferoxamine—XDH—Metabolism—CETP—coronary artery disease	5.58e-05	0.00082	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GCLC—coronary artery disease	5.58e-05	0.00082	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—SDC1—coronary artery disease	5.52e-05	0.000811	CbGpPWpGaD
Deferoxamine—Nausea—Lisinopril—coronary artery disease	5.3e-05	0.000274	CcSEcCtD
Deferoxamine—XDH—Metabolism—PSMB5—coronary artery disease	5.21e-05	0.000766	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PSMA6—coronary artery disease	5.21e-05	0.000766	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CTGF—coronary artery disease	5.09e-05	0.000749	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GOT2—coronary artery disease	5.05e-05	0.000742	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMGCR—coronary artery disease	5.05e-05	0.000742	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PLCB1—coronary artery disease	4.64e-05	0.000682	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ABCA1—coronary artery disease	4.5e-05	0.000661	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GGT1—coronary artery disease	4.36e-05	0.000641	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GOT1—coronary artery disease	4.36e-05	0.000641	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTP1—coronary artery disease	3.91e-05	0.000575	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARGC1A—coronary artery disease	3.88e-05	0.00057	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—HMOX1—coronary artery disease	3.86e-05	0.000567	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CAT—coronary artery disease	3.81e-05	0.00056	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOB—coronary artery disease	3.7e-05	0.000544	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GSTM1—coronary artery disease	3.6e-05	0.000529	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—LPL—coronary artery disease	3.53e-05	0.000519	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—GPX1—coronary artery disease	3.44e-05	0.000506	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—CD36—coronary artery disease	3.35e-05	0.000493	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPP2CA—coronary artery disease	3.31e-05	0.000487	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—MTHFR—coronary artery disease	3.18e-05	0.000467	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AGT—coronary artery disease	3.02e-05	0.000444	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOE—coronary artery disease	2.96e-05	0.000435	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—APOA1—coronary artery disease	2.93e-05	0.00043	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PPARG—coronary artery disease	2.58e-05	0.000379	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—POMC—coronary artery disease	2.54e-05	0.000374	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—ALB—coronary artery disease	2.32e-05	0.000341	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—NOS3—coronary artery disease	2.22e-05	0.000326	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PTGS2—coronary artery disease	2.03e-05	0.000298	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—PIK3CA—coronary artery disease	1.25e-05	0.000183	CbGpPWpGaD
Deferoxamine—XDH—Metabolism—AKT1—coronary artery disease	1.02e-05	0.00015	CbGpPWpGaD
